Physic Ventures
  • Home
  • Purpose
  • Strategy
  • Leadership
    • Management Team
      • Dion Madsen, CFA
      • William Rosenzweig
      • Andy Donner
      • Andrew Williamson, PhD
      • Stacy Feld, JD
      • Christina LaMontagne
      • Jean Fréchet, PhD
      • David Lawrence, MD, MPH
      • Phil Giesler
      • Michael Hammer
      • Patty O'Malley
      • Rita Anderson
      • Dana Fredsti
      • Carrie-Andrea Kaye
    • Advisory Board
      • Stephen Dilly, MD, PhD
      • Bruce German, PhD
      • Andrew Hargadon, PhD
      • Ellen R. Marram
      • Bradley A. Perkins, MD
  • Portfolio
    • Chromatin
    • Elixir
    • EnergyHub
    • Gazelle
    • GoodGuide
    • HaloSource
    • Impinj
    • Merrimack
    • Novomer
    • On-Q-ity
    • Pharmaca
    • SurfaceLogix
    • T2 Biosystems
    • Textronics
  • Investors
  • News/Events
    • Portfolio News
    • Physic News
    • Industry Links
    • Events
  • Contact

Chromatin

Chromatin is a biotech company developing innovative technologies that benefit the agricultural, energy, chemical, nutritional, and pharmaceutical sectors. Chromatin is commercializing solutions which proactively address key societal challenges such as improving agricultural productivity and increasing renewable energy resources.

www.chromatininc.com
  • Recent News
  • News Archive

Recent News

  • Chromatin, Inc. Acquires Sorghum Partners, Inc. (SPI) and Milo Genetics, LP, Release, April 28, 2010
  • Chromatin Licenses Gene Stacking Technology for Sugar cane to Syngenta, Release, June 26, 2009
  • iCon Award to Chromatin's Preuss, iBIO Institute, October 15, 2008

News Archive

No Archived Articles

  • Chromatin
  • Elixir
  • EnergyHub
  • Gazelle
  • GoodGuide
  • HaloSource
  • Impinj
  • Merrimack
  • Novomer
  • On-Q-ity
  • Pharmaca
  • SurfaceLogix
  • T2 Biosystems
  • Textronics
Careers | Contact | © Copyright 2007-2009 Physic Ventures, LLC